T HAS BEEN SHOWN IN SEVERAL 1-6 BUT not all studies 7-9 that job strain, a combination of high psychological demands and low decision latitude, 10 increases the risk of a first coronary heart disease (CHD) event. However, the association of job strain with the risk of recurrent CHD events after a first myocardial infarction (MI) has been documented in only 2 prospective studies whose findings were inconsistent. 11,12 Two major limitations of these previous studies were that they did not assess the duration of psychosocial work exposure 11-13 and were conducted with a limited number of participants (n=62, 11 n=200 12). Our study was undertaken to determine whether job strain increases the risk of recurrent CHD events when the duration of psychosocial work exposure is taken into account in a large cohort who returned to work after a first recent MI. METHODS Patients and Data Collection A total of 1191 patients younger than 60 years were recruited from 30 hospitals in the province of Quebec, Canada, between November 1995 and October 1997. Eligible patients had a first acute MI, held a paid job in the 12 months before their MI, and planned to return to work at least 10 hours per week within 18 months after their MI. The ethics board of each hospital approved the study. Written informed consent was obtained before hospital discharge. The final study population included 972 patients (FIGURE 1). Medical information regarding the acute MI and past medical history was documented during the first hospitalization. Participants were interviewed 3 times by telephone: at baseline in 1996-1998, an average of 6 weeks after their return to work, 2.2 years later in 1998-2000, and after 6.9 years in 2003-2005. Validated questionnaires for the first 2 inter-See also p 1693 and Patient Page.
Incidence of intracerebral haemorrhage over the past three decades is reported as stable. This disappointing finding is questionable and suggests that any reduction in intracerebral haemorrhage incidence associated with improvements in primary prevention, namely, better control of blood pressure, might have been offset by an increase in cases of intracerebral haemorrhage owing to other factors, including the use of antithrombotic drugs in the ageing population. Therefore, we aimed to analyse trends in intracerebral haemorrhage incidence from 1985 to 2008 in the population-based registry of Dijon, France, taking into consideration the intracerebral haemorrhage location, the effect of age and the changes in the distribution of risk factors and premorbid treatments. Incidence rates were calculated and temporal trends were analysed by age groups (<60, 60-74 and ≥75 years) and intracerebral haemorrhage location (lobar or deep) according to study periods 1985-92, 1993-2000 and 2001-08. Over the 24 years of the study, 3948 patients with first-ever stroke were recorded. Among these, 441 had intracerebral haemorrhage (48.3% male), including 49% lobar, 37% deep, 9% infratentorial and 5% of undetermined location. Mean age at onset increased from 67.3 ± 15.9 years to 74.7 ± 16.7 years over the study period (P < 0.001). Overall crude incidence was 12.4/100,000/year (95% confidence interval: 11.2-13.6) and remained stable over time. However, an ∼80% increase in intracerebral haemorrhage incidence among people aged ≥75 years was observed between the first and both second and third study periods, contrasting with a 50% decrease in that in individuals aged <60 years, and stable incidence in those aged 60-74 years. This result was attributed to a 2-fold increase in lobar intracerebral haemorrhage in the elderly, concomitantly with an observed rise in the premorbid use of antithrombotics at this age, whatever the intracerebral haemorrhage location considered. In conclusion, intracerebral haemorrhage profiles have changed in the past 20 years, suggesting that some bleeding-prone vasculopathies in the elderly are more likely to bleed when antithrombotic drugs are used, as illustrated by the rise in the incidence of lobar intracerebral haemorrhage in the elderly, in which cerebral amyloid angiopathy may be strongly implicated. Future research should focus on the impact and management of antithrombotics in patients with intracerebral haemorrhage, which may differ according to the underlying vessel disease.
Population-based stroke registries can provide valid stroke incidence because they ensure exhaustiveness of case ascertainment. However, their results are difficult to extrapolate because they cover a small population. The French Hospital Discharge Database (FHDDB), which routinely collects administrative data, could be a useful tool for providing data on the nationwide burden of stroke. The aim of our pilot study was to assess the validity of stroke diagnosis reported in the FHDDB. All records of patients with a diagnosis of stroke between 2004 and 2008 were retrieved from the FHDDB of Dijon Teaching Hospital. The Dijon Stroke Registry was considered as the gold standard. The sensitivity, positive predictive value (PPV), and weighted kappa were calculated. The Dijon Stroke Registry identified 811 patients with a stroke, among whom 186 were missed by the FHDDB and thus considered false-negatives. The FHDDB identified 903 patients discharged following a stroke including 625 true-positives confirmed by the registry and 278 false-positives. The overall sensitivity and PPV of the FHDDB for the diagnosis of stroke were, respectively, 77.1 % (95 % CI 74.2–80) and 69.2 % (95 % CI 66.1–72.2). For cardioembolic and lacunar strokes, the FHDDB yielded higher PPVs (respectively 86.7 and 84.6 %; p < 0.0001) than those of other stroke subtypes. The PPV but not sensitivity significantly increased over the years (p < 0.0001). Agreement with the stroke registry was moderate (kappa 52.8; 95 % CI 46.8–58.9). The FHDDB-based stroke diagnosis showed moderate validity compared with the Dijon Stroke Registry as the gold standard. However, its accuracy (PPV) increased with time and was higher for some stroke subtypes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.